Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy

SGLT2 inhibitors improved time in range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective single‐center pilot study

(2020) Daisuke Suzuki et al.   Journal of Diabetes Investigation

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes

(2020) Qingyu Guo et al.   Journal of Diabetes Research

Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin

(2020) Yen-Wei Pai et al.   DIABETES & METABOLISM

Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

(2020) Maria Ida Maiorino et al.   DIABETES CARE

Relationship of ankle-brachial index, vibration perception threshold, and current perception threshold to glycemic variability in type 2 diabetes

(2020) Chuangbiao Zhang et al.   MEDICINE

The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats

(2019) Junpeng Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Painful and Painless Diabetic Neuropathies: What Is the Difference?

(2019) Pallai Shillo et al.   Current Diabetes Reports

Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus

(2019) Mohammad Alkhatatbeh et al.   BMJ Open Diabetes Research & Care

Time in range is associated with carotid intima-media thickness in type 2 diabetes

(2019) Jingyi Lu et al.   Diabetes Technology & Therapeutics

Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late

(2019) S. Javed et al.   DIABETIC MEDICINE

Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes

(2018) Yen-Wei Pai et al.   DIABETES & METABOLISM

Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes

(2018) Eleanor M. Scott et al.   Diabetes Technology & Therapeutics

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

(2018) Jingyi Lu et al.   DIABETES CARE

Risk factors for neuropathic pain in diabetes mellitus

(2017) Harry L. Hébert et al.   PAIN

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

(2016) Rodica Pop-Busui et al.   DIABETES CARE

The Pain in Neuropathy Study (PiNS)

(2016) Andreas C. Themistocleous et al.   PAIN

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Relationship between ultrasonographic nerve morphology and severity of diabetic sensorimotor polyneuropathy

(2015) T. Arumugam et al.   EUROPEAN JOURNAL OF NEUROLOGY

C-Peptide Is Independently Associated with an Increased Risk of Coronary Artery Disease in T2DM Subjects: A Cross-Sectional Study

(2015) Lingshu Wang et al.   PLoS One

Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

(2011) C. A. Abbott et al.   DIABETES CARE

Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics

(2009) K. Van Acker et al.   DIABETES & METABOLISM

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE